These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 17538996)

  • 1. Liver transplantation for hepatocellular carcinoma: the hepatitis C quandary.
    Yao FY
    Liver Transpl; 2007 Jun; 13(6):783-5. PubMed ID: 17538996
    [No Abstract]   [Full Text] [Related]  

  • 2. Survival outcomes in liver transplantation for hepatocellular carcinoma, comparing impact of hepatitis C versus other etiology of cirrhosis.
    Bozorgzadeh A; Orloff M; Abt P; Tsoulfas G; Younan D; Kashyap R; Jain A; Mantry P; Maliakkal B; Khorana A; Schwartz S
    Liver Transpl; 2007 Jun; 13(6):807-13. PubMed ID: 17539001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Liver transplantation for hepatocellular carcinoma: status quo and experience in Kyushu University].
    Soejima Y; Taketomi A; Ikegami T; Yoshizumi T; Uchiyama H; Gion T; Sugimachi K; Nagata S; Maehara Y
    Fukuoka Igaku Zasshi; 2008 May; 99(5):95-101. PubMed ID: 18788452
    [No Abstract]   [Full Text] [Related]  

  • 4. Accuracy of staging as a predictor for recurrence after liver transplantation for hepatocellular carcinoma.
    Reddy MS; Manas DM
    Transplantation; 2007 Feb; 83(3):367-8. PubMed ID: 17297420
    [No Abstract]   [Full Text] [Related]  

  • 5. Role of adult living liver donation in patients with hepatocellular cancer.
    Roberts JP
    Liver Transpl; 2003 Oct; 9(10 Suppl 2):S60-3. PubMed ID: 14528431
    [No Abstract]   [Full Text] [Related]  

  • 6. Characterization of hepatocellular carcinoma developed after achieving sustained virological response to interferon therapy for hepatitis C.
    Sanefuji K; Kayashima H; Iguchi T; Sugimachi K; Yamashita Y; Yoshizumi T; Soejima Y; Nishizaki T; Taketomi A; Maehara Y
    J Surg Oncol; 2009 Jan; 99(1):32-7. PubMed ID: 18985618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical management of hepatocellular carcinoma: is the jury still out?
    Morris-Stiff G; Gomez D; de Liguori Carino N; Prasad KR
    Surg Oncol; 2009 Dec; 18(4):298-321. PubMed ID: 19062271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selection criteria for patients with hepatocellular carcinoma in liver transplantation.
    Kaido T; Takada Y; Uemoto S
    Transplantation; 2009 Aug; 88(3):442-3; author reply 443. PubMed ID: 19667951
    [No Abstract]   [Full Text] [Related]  

  • 9. Liver resection and liver transplantation in hepatocellular carcinoma.
    Franco D
    Rev Gastroenterol Mex; 1996; 61(4 Suppl 2):S94. PubMed ID: 8986104
    [No Abstract]   [Full Text] [Related]  

  • 10. Interferon: benefit beyond hepatitis therapy?
    Mallat DB; El-Serag HB
    Am J Gastroenterol; 2001 Dec; 96(12):3435-6. PubMed ID: 11774964
    [No Abstract]   [Full Text] [Related]  

  • 11. Rapidly progressive recurrent hepatitis C virus infection starting 9 days after liver transplantation.
    Saraf N; Fiel MI; Deboccardo G; Emre S; Schiano TD
    Liver Transpl; 2007 Jun; 13(6):913-7. PubMed ID: 17539015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can the prognosis of liver transplantation for hepatocellular carcinoma be predicted?
    Ringe B
    Hepatology; 1997 Aug; 26(2):507-8. PubMed ID: 9252168
    [No Abstract]   [Full Text] [Related]  

  • 13. Liver transplantation for hepatocellular carcinoma: how far can we push the envelope?
    Tan KC
    Singapore Med J; 2003 Jun; 44(6):309-11. PubMed ID: 14560865
    [No Abstract]   [Full Text] [Related]  

  • 14. Summaries for patients. Does interferon-alpha prevent recurrence of malignant tumors in patients with hepatitis C - related liver cancer?
    Ann Intern Med; 2001 May; 134(10):S-7. PubMed ID: 11357861
    [No Abstract]   [Full Text] [Related]  

  • 15. Salvage live donor liver transplantation for a second recurrence of hepatocellular carcinoma.
    Sotiropoulos GC; Treckmann JW; Molmenti EP; Schmitz KJ; Cicinnati VR; Paul A; Broelsch CE; Malagó M
    Transpl Int; 2008 Feb; 21(2):182-5. PubMed ID: 17971034
    [No Abstract]   [Full Text] [Related]  

  • 16. [Strategy to improve the prognosis of liver transplantation for hepatocellular carcinoma].
    Fan J; Xu Y
    Zhonghua Wai Ke Za Zhi; 2008 Nov; 46(21):1602-5. PubMed ID: 19094749
    [No Abstract]   [Full Text] [Related]  

  • 17. Liver transplantation: the preferred treatment for early hepatocellular carcinoma in the setting of cirrhosis?
    Schwartz M
    Ann Surg Oncol; 2007 Feb; 14(2):548-52. PubMed ID: 17009143
    [No Abstract]   [Full Text] [Related]  

  • 18. Response to interferon therapy affects risk factors for postoperative recurrence of hepatitis C virus-related hepatocellular carcinoma.
    Uenishi T; Nishiguchi S; Tanaka S; Yamamoto T; Takemura S; Kubo S
    J Surg Oncol; 2008 Oct; 98(5):358-62. PubMed ID: 18646001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver transplantation outcomes in patients with cirrhosis and hepatocellular carcinoma: experience of a single center in a viral hepatitis endemic area.
    Imvrios G; Papanikolaou V; Vrochides D; Ouzounidis N; Papagiannis A; Fouzas I; Giakoustidis D; Antoniades N; Iosifidou S; Patsiaoura K; Zafiriadou E; Takoudas D
    Transplant Proc; 2007 Jun; 39(5):1508-10. PubMed ID: 17580174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural killer cells play divergent roles in shaping the outcome of hepatitis C virus recurrence following liver transplantation.
    Golden-Mason L
    Liver Transpl; 2009 Apr; 15(4):357-9. PubMed ID: 19326413
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.